Nipple-Sparing Mastectomy (NSM)

Rodrigo Arrangoiz MS, MD, FACS, FSSO

popup-mastectomy_lg

  • NSM is an oncologically sound option for selected breast cancer patients (as it is for prophylaxis) but there is no clear consensus as to the selection criteria:
    • Based on careful anatomic studies and recent comprehensive reviews:
      • Nipple involvement was present in 11.5% of reported NSM procedures, and was associated with:
        • Tumor-to-nipple distance of less than 2 cm
        • Positive nodes
        • Lymphovascular invasion
        • ER/PR-negative
        • HER2-positive
        • Locally advanced
        • Retroareolar
        • Multicentric tumors
    • Local recurrence occurred more frequently in the skin flaps (4.2%) than in the nipple (0.9%).
    • Nipple necrosis was:
      • Partial thickness in 6.3% of patients
      • Full thickness in 2.9% of patients
    • A negative nipple margin is necessary for NSM but is not sufficient for patients whose tumors are otherwise unsuitable (see risk factors above).
    • NSM is also not suitable for patients:
      • Whose breasts are very large and / or ptotic
      • Who are elderly
      • Who have significant comorbidities

nipple-sparing-mastectomy

 

Rodrigo Arrangoiz MS, MD, FACS a surgical oncologist and is a member of Sociedad Quirúrgica S.C at the America British Cowdray Medical Center in Mexico City:

  • He is an expert in the management of breast cancer.

    • If you have any questions about the screening for breast cancer please fill free to contact Dr. Arrangoiz.

20d943b1-6f20-49c3-9754-2f3756051c93

Training:

• General surgery:

• Michigan State University:

• 2004 al 2010

• Surgical Oncology / Head and Neck Surgery / Endocrine Surgery:

• Fox Chase Cancer Center (Filadelfia):

• 2010 al 2012

• Masters in Science (Clinical research for health professionals):

• Drexel University (Filadelfia):

• 2010 al 2012

• Surgical Oncology / Head and Neck Surgery / Endocrine Surgery:

• IFHNOS / Memorial Sloan Kettering Cancer Center:

• 2014 al 2016

#Arrangoiz

#Surgeon

#Cirujano

#SurgicalOncologist

#CirujanoOncologo

#BreastSurgeon

#CirujanodeMama

#CancerSurgeon

#CirujanodeCancer

http://www.sociedadquirurigca.com

Unknown's avatar

Published by Rodrigo Arrangoiz MS, MD, FACS, FSSO

My name is Rodrigo Arrangoiz I am a breast surgeon/ thyroid surgeon / parathyroid surgeon / head and neck surgeon / surgical oncologist that works at Center for Advanced Surgical Oncology in Miami, Florida. I was trained as a surgeon at Michigan State University from (2005 to 2010) where I was a chief resident in 2010. My surgical oncology and head and neck training was performed at the Fox Chase Cancer Center in Philadelphia from 2010 to 2012. At the same time I underwent a masters in science (Clinical research for health professionals) at the University of Drexel. Through the International Federation of Head and Neck Societies / Memorial Sloan Kettering Cancer Center I performed a two year head and neck surgery and oncology / endocrine fellowship that ended in 2016. Mi nombre es Rodrigo Arrangoiz, soy cirujano oncólogo / cirujano de tumores de cabeza y cuello / cirujano endocrino que trabaja Center for Advanced Surgical Oncology en Miami, Florida. Fui entrenado como cirujano en Michigan State University (2005 a 2010 ) donde fui jefe de residentes en 2010. Mi formación en oncología quirúrgica y e n tumores de cabeza y cuello se realizó en el Fox Chase Cancer Center en Filadelfia de 2010 a 2012. Al mismo tiempo, me sometí a una maestría en ciencias (investigación clínica para profesionales de la salud) en la Universidad de Drexel. A través de la Federación Internacional de Sociedades de Cabeza y Cuello / Memorial Sloan Kettering Cancer Center realicé una sub especialidad en cirugía de cabeza y cuello / cirugia endocrina de dos años que terminó en 2016.

Leave a comment